Janet Murbartián

Dr. Janet Murbartián

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
ÚFÚrzula Franco‐Enzástiga
Úrzula Franco‐Enzástiga
GGGuadalupe García
Guadalupe García
JMJanet Murbartián
Janet Murbartián
RGRodrigo González‐Barrios
Rodrigo González‐Barrios
ASAna B. Salinas‐Abarca
Ana B. Salinas‐Abarca
VGVinicio Granados-Soto
Vinicio Granados-Soto

1 April 2019 in Neuroscience
Verified
Journal Article
Closed access
GGGuadalupe García
Guadalupe García
EGErika J. Gutiérrez-Lara
Erika J. Gutiérrez-Lara
David CenturiónDavid Centurión
David Centurión
VGVinicio Granados-Soto
Vinicio Granados-Soto
JMJanet Murbartián
Janet Murbartián

1 September 2014 in Brain Research
Verified
Journal Article
Closed access
GGGuadalupe García
Guadalupe García
VMVladimir A. Martínez-Rojas
Vladimir A. Martínez-Rojas
HRHéctor I. Rocha-González
Héctor I. Rocha-González
VGVinicio Granados-Soto
Vinicio Granados-Soto
JMJanet Murbartián
Janet Murbartián

1 December 2017 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
VMVladimir A. Martínez-Rojas
Vladimir A. Martínez-Rojas
GGGuadalupe García
Guadalupe García
RNRoxana Noriega-Navarro
Roxana Noriega-Navarro
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
JTJorge E Torres-Lopez
Jorge E Torres-Lopez
JMJanet Murbartián
Janet Murbartián
Background: Transient receptor potential ankyrin 1 (TRPA1) is a non-selective cation channel expressed by a subset of nociceptive neurons that acts as a multimodal receptor. Its activity contributes to modulate nociceptive transmission in acute inflammatory pain. However, the role of this channel in chronic pain has been less studied. The purpose of this study was to investigate the local peripheral and spinal participation of TRPA1 channels in formalin-induced long-lasting hypersensitivity. Materials and methods: Formalin (1%)-induced chronic hypersensitivity was determined by the application of von Frey filaments to ipsilateral and contralateral paws and through pharmacological testing using a selective TRPA1 blocker (A-967079). TRPA1 expression in the dorsal root ganglion (DRG) and spinal cord was analyzed by Western blotting. Results: Formalin (1%) injection produced acute flinching behavior (1 h) as well as secondary allodynia and hyperalgesia (12 days). Local peripheral pretreatment (10 min before) or posttreatment (6 days later) with A-967079 (1–100 µM) partially prevented and reversed, respectively, in a dose-dependent manner, long-lasting secondary mechanical allodynia and hyperalgesia evoked by 1% formalin. Likewise, intrathecal pretreatment or posttreatment with A-967079 partially prevented and reversed, respectively, formalin-induced long-lasting hypersensitivity. A-967079 (100 µM) completely abolished the pro-nociceptive effect of formalin (adjusted to pH 7.4). Finally, formalin injection increased TRPA1 protein expression in the DRG and spinal cord. Conclusion: Results indicate that TRPA1 expressed in the DRG and spinal cord plays a relevant role in formalin-induced long-lasting secondary nociceptive hypersensitivity.

2 October 2020 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
GGGuadalupe García
Guadalupe García
KMKarina A. Méndez‐Reséndiz
Karina A. Méndez‐Reséndiz
Norma Angélica OviedoNorma Angélica Oviedo
Norma Angélica Oviedo
JMJanet Murbartián
Janet Murbartián

3 July 2021 in Behavioural Brain Research
Verified
Journal Article
Closed access
GGGuadalupe García
Guadalupe García
VMVladimir A. Martínez-Rojas
Vladimir A. Martínez-Rojas
JMJanet Murbartián
Janet Murbartián